BILLING NEWS

MolDX: Cystatin C Measurement Final LCD - Effective February 11, 2019

Medicare Coverage Database (MCD) Number/Contractor Determination Number: L37618
LCD Title: MolDX: Cystatin C Measurement
Effective Date: February 11, 2019
Summary of LCD: Cystatin C is a low molecular weight protein produced by all nucleated cells in the body at a constant rate. It has been proposed and investigated as an improved marker of renal function and as a potential alternative to serum creatinine based estimated glomerular filtration rate (eGFR), as well as a biomarker for predicting cardiovascular risk.


INDUSTRY NEWS TAGS: CMS


Share This Post:

Search Billing News

Billing News By TAG

Billing News By DATE